CHEK1 and cancer: Cancer cells may reportedly depend on the ATR-CHK1 signaling pathway and intact S/G2-M checkpoints for repairing DNA damage [116], and thus, ATR inhibition may result in selective cytotoxic DNA damage and detrimental mitotic catastrophe to tumor cells, while normal cells with a functional G1 checkpoint will be unaffected.